Uterine Factors

Obstetrics and Gynecology Clinics of North America

Volumn 41, Issue 1, 2014, Pages 57-86

  Jaslow, Carolyn R ^a  

^a RHODES COLLEGE   (United States)

Author keywords

Acquired; Congenital; Fibroids; Pregnancy loss; Recurrent miscarriage; Septum; Uterine anomalies; Uterus

Indexed keywords

ACQUIRED; CONGENITAL; FIBROIDS; PREGNANCY LOSS; RECURRENT MISCARRIAGE; SEPTUM; UTERINE ANOMALIES; UTERUS;

ABORTION, HABITUAL; FEMALE; HUMANS; HYSTEROSCOPY; LEIOMYOMA; MULLERIAN DUCTS; POLYPS; PREGNANCY; TISSUE ADHESIONS; UROGENITAL ABNORMALITIES; UTERINE DISEASES; UTERUS;

EID: 84893390819     PISSN: 08898545     EISSN: 15580474     Source Type: Journal    
DOI: 10.1016/j.ogc.2013.10.002     Document Type: Review

References (165)

1. Sugiura-Ogasawara M., Suzuki S., Ozaki Y., et al. Frequency of recurrent spontaneous abortion and its influence on further marital relationship and illness: the Okazaki Cohort Study in Japan. JObstet Gynaecol Res 2013, 39:126-131.
2. Klock S.C., Chang G., Hiley A., et al. Psychological distress among women with recurrent spontaneous abortion. Psychosomatics 1997, 38:503-507.
3. Sugiura-Ogasawara M., Ozaki Y., Katano K., et al. Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage. Hum Reprod 2012, 27:2297-2303.
4. Jauniaux E., Farquharson R.G., Christiansen O.B., et al. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 2006, 21:2216-2222.
5. Jaslow C.R., Carney J.L., Kutteh W.H. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril 2010, 93:1234-1243.
6. Chan Y.Y., Jayaprakasan K., Zamora J., et al. The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review. Hum Reprod Update 2011, 17:761-771.
7. Saravelos S.H., Cocksedge K.A., Li T.C. Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal. Hum Reprod Update 2008, 14:415-429.
8. American Association of Gynecologic Laparoscopists: Advancing Minimally Invasive Gynecology Worldwide AAGL practice report: practice guidelines for the diagnosis and management of submucous leiomyomas. JMinim Invasive Gynecol 2012, 19:152-171.
9. AAGL Advancing Minimally Invasive Gynecology Worldwide AAGL practice report: practice guidelines for management of intrauterine synechiae. JMinim Invasive Gynecol 2010, 17:1-7.
10. Salim S., Won H., Nesbitt-Hawes E., et al. Diagnosis and management of endometrial polyps: a critical review of the literature. JMinim Invasive Gynecol 2011, 18:569-581.
11. Salim R., Lee C., Davies A., et al. Acomparative study of three-dimensional saline infusion sonohysterography and diagnostic hysteroscopy for the classification of submucous fibroids. Hum Reprod 2005, 20:253-257.
12. Hashimoto R. Development of the human Müllerian duct in the sexually undifferentiated stage. Anat Rec A Discov Mol Cell Evol Biol 2003, 272:514-519.
13. Lee D.M., Osathanondh R., Yeh J. Localization of Bcl-2 in the human fetal Müllerian tract. Fertil Steril 1998, 70:135-140.
14. Toaff M.E., Lev-Toaff A.S., Toaff R. Communicating uteri: review and classification with introduction of two previously unreported types. Fertil Steril 1984, 41:661-679.
15. Guioli S., Sekido R., Lovell-Badge R. The origin of the Müllerian duct in chick and mouse. Dev Biol 2007, 302:389-398.
16. Orvis G.D., Behringer R.R. Cellular mechanisms of Müllerian duct formation in the mouse. Dev Biol 2007, 306:493-504.
17. Masse J., Watrin T., Laurent A., et al. The developing female genital tract: from genetics to epigenetics. Int J Dev Biol 2009, 53:411-424.
18. Kurita T., Cooke P.S., Cunha G.R. Epithelial-stromal tissue interaction in paramesonephric (Müllerian) epithelial differentiation. Dev Biol 2001, 240:194-211.
19. Kitajewski J., Sassoon D. The emergence of molecular gynecology: homeobox and Wnt genes in the female reproductive tract. Bioessays 2000, 22:902-910.
20. Miller C., Sassoon D.A. Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 1998, 125:3201-3211.
21. Taylor H.S., Vanden Heuvel G.B., Igarashi P. Aconserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Biol Reprod 1997, 57:1338-1345.
22. Cunha G.R., Young P., Brody J.R. Role of uterine epithelium in the development of myometrial smooth muscle cells. Biol Reprod 1989, 40:861-871.
23. AFS The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Müllerian anomalies and intrauterine adhesions. Fertil Steril 1988, 49:944-955.
24. Kara T., Acu B., Beyhan M., et al. MRI in the diagnosis of Mayer-Rokitansky-Kuster-Hauser syndrome. Diagn Interv Radiol 2013, 19:227-232.
25. Acien P., Acien M.I. The history of female genital tract malformation classifications and proposal of an updated system. Hum Reprod Update 2011, 17:693-705.
26. Reichman D., Laufer M.R., Robinson B.K. Pregnancy outcomes in unicornuate uteri: a review. Fertil Steril 2009, 91:1886-1894.
27. Nahum G.G. Uterine anomalies. How common are they, and what is their distribution among subtypesα. JReprod Med 1998, 43:877-887.
28. Nahum G.G., Stanislaw H., McMahon C. Preventing ectopic pregnancies: how often does transperitoneal transmigration of sperm occur in effecting human pregnancyα. BJOG 2004, 111:706-714.
29. Taylor E., Gomel V. The uterus and fertility. Fertil Steril 2008, 89:1-16.
30. Troiano R.N., McCarthy S.M. Müllerian duct anomalies: imaging and clinical issues. Radiology 2004, 233:19-34.
31. Homer H.A., Li T.C., Cooke I.D. The septate uterus: a review of management and reproductive outcome. Fertil Steril 2000, 73:1-14.
32. Pellerito J.S., McCarthy S.M., Doyle M.B., et al. Diagnosis of uterine anomalies: relative accuracy of MR imaging, endovaginal sonography, and hysterosalpingography. Radiology 1992, 183:795-800.
33. Reuter K.L., Daly D.C., Cohen S.M. Septate versus bicornuate uteri: errors in imaging diagnosis. Radiology 1989, 172:749-752.
34. Reichman D.E., Laufer M.R. Congenital uterine anomalies affecting reproduction. Best Pract Res Clin Obstet Gynaecol 2010, 24:193-208.
35. Grimbizis G.F., Campo R. Clinical approach for the classification of congenital uterine malformations. Gynecol Surg 2012, 9:119-129.
36. Sparac V., Kupesic S., Ilijas M., et al. Histologic architecture and vascularization of hysteroscopically excised intrauterine septa. JAm Assoc Gynecol Laparosc 2001, 8:111-116.
37. Candiani G.B., Fedele L., Zamberletti D., et al. Endometrial patterns in malformed uteri. Acta Eur Fertil 1983, 14:311-318.
38. Dabirashrafi H., Bahadori M., Mohammad K., et al. Septate uterus: new idea on the histologic features of the septum in this abnormal uterus. Am J Obstet Gynecol 1995, 172:105-107.
39. Makino T., Umeuchi M., Nakada K., et al. Incidence of congenital uterine anomalies in repeated reproductive wastage and prognosis for pregnancy after metroplasty. Int J Fertil 1992, 37:167-170.
40. Woelfer B., Salim R., Banerjee S., et al. Reproductive outcomes in women with congenital uterine anomalies detected by three-dimensional ultrasound screening. Obstet Gynecol 2001, 98:1099-1103.
41. Sørensen S.S., Trauelsen A.G. Obstetric implications of minor Müllerian anomalies in oligomenorrheic women. Am J Obstet Gynecol 1987, 156:1112-1118.
42. Valli E., Zupi E., Marconi D., et al. Hysteroscopic findings in 344 women with recurrent spontaneous abortion. JAm Assoc Gynecol Laparosc 2001, 8:398-401.
43. Lin P.C., Bhatnagar K.P., Nettleton G.S., et al. Female genital anomalies affecting reproduction. Fertil Steril 2002, 78:899-915.
44. Ghi T., Casadio P., Kuleva M., et al. Accuracy of three-dimensional ultrasound in diagnosis and classification of congenital uterine anomalies. Fertil Steril 2009, 92:808-813.
45. Jaslow C.R., Kutteh W.H. Effect of prior birth and miscarriage frequency on the prevalence of acquired and congenital uterine anomalies in women with recurrent miscarriage: a cross-sectional study. Fertil Steril 2013, 99:1916-1922.e1.
46. Salim R., Regan L., Woelfer B., et al. Acomparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod 2003, 18:162-166.
47. Stephenson M.D. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 1996, 66:24-29.
48. Kaufman R.H., Binder G.L., Gray P.M., et al. Upper genital tract changes associated with exposure in utero to diethylstilbestrol. Am J Obstet Gynecol 1977, 128:51-59.
49. Ma L., Benson G.V., Lim H., et al. Abdominal B (AbdB) Hoxa genes: regulation in adult uterus by estrogen and progesterone and repression in Müllerian duct by the synthetic estrogen diethylstilbestrol (DES). Dev Biol 1998, 197:141-154.
50. Suzuki A., Urushitani H., Sato T., et al. Gene expression change in the Müllerian duct of the mouse fetus exposed to diethylstilbestrol in utero. Exp Biol Med (Maywood) 2007, 232:503-514.
51. Block K., Kardana A., Igarashi P., et al. In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing Müllerian system. FASEB J 2000, 14:1101-1108.
52. Goodman F.R., Bacchelli C., Brady A.F., et al. Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am J Hum Genet 2000, 67:197-202.
53. Cheng Z., Zhu Y., Su D., et al. Anovel mutation of HOXA10 in a Chinese woman with a Müllerian duct anomaly. Hum Reprod 2011, 26:3197-3201.
54. Hammoud A.O., Gibson M., Peterson C.M., et al. Quantification of the familial contribution to Müllerian anomalies. Obstet Gynecol 2008, 111:378-384.
55. Elias S., Simpson J.L., Carson S.A., et al. Genetics studies in incomplete Müllerian fusion. Obstet Gynecol 1984, 63:276-279.
56. Souza C.A., Schmitz C., Genro V.K., et al. Office hysteroscopy study in consecutive miscarriage patients. Rev Assoc Med Bras 2011, 57:397-401.
57. Weiss A., Shalev E., Romano S. Hysteroscopy may be justified after two miscarriages. Hum Reprod 2005, 20:2628-2631.
58. Bohlmann M.K., von Wolff M., Luedders D.W., et al. Hysteroscopic findings in women with two and with more than two first-trimester miscarriages are not significantly different. Reprod Biomed Online 2010, 21:230-236.
59. Bax L. MIX 2.0. Professional software for meta-analysis in Excel. Version (2.0.1.4). 2011. Available at: Accessed May 24, 2012. http://www.meta-analysis-made-easy.com.
60. Tulppala M., Palosuo T., Ramsay T., et al. Aprospective study of 63 couples with a history of recurrent spontaneous abortion: contributing factors and outcome of subsequent pregnancies. Hum Reprod 1993, 8:764-770.
61. Hanley J.A., Lippman-Hand A. If nothing goes wrong, is everything all rightα Interpreting zero numerators. JAMA 1983, 249:1743-1745.
62. Warburton D., Fraser F.C. Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. Am J Hum Genet 1964, 16:1-25.
63. Nybo Andersen A.M., Wohlfahrt J., Christens P., et al. Maternal age and fetal loss: population based register linkage study. BMJ 2000, 320:1708-1712.
64. Chan Y.Y., Jayaprakasan K., Tan A., et al. Reproductive outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound Obstet Gynecol 2011, 38:371-382.
65. Jayaprakasan K., Chan Y.Y., Sur S., et al. Prevalence of uterine anomalies and their impact on early pregnancy in women conceiving after assisted reproduction treatment. Ultrasound Obstet Gynecol 2011, 37:727-732.
66. Raga F., Bauset C., Remohi J., et al. Reproductive impact of congenital Müllerian anomalies. Hum Reprod 1997, 12:2277-2281.
67. Zlopasa G., Skrablin S., Kalafatic D., et al. Uterine anomalies and pregnancy outcome following resectoscope metroplasty. Int J Gynaecol Obstet 2007, 98:129-133.
68. Saravelos S.H., Cocksedge K.A., Li T.C. The pattern of pregnancy loss in women with congenital uterine anomalies and recurrent miscarriage. Reprod Biomed Online 2010, 20:416-422.
69. Fedele L., Dorta M., Brioschi D., et al. Pregnancies in septate uteri: outcome in relation to site of uterine implantation as determined by sonography. AJR Am J Roentgenol 1989, 152:781-784.
70. Fedele L., Bianchi S., Marchini M., et al. Ultrastructural aspects of endometrium in infertile women with septate uterus. Fertil Steril 1996, 65:750-752.
71. Leible S., Cumsille F., Walton R., et al. Discordant uterine artery velocity waveforms as a predictor of subsequent miscarriage in early viable pregnancies. Am J Obstet Gynecol 1998, 179:1587-1593.
72. Leible S., Munoz H., Walton R., et al. Uterine artery blood flow velocity waveforms in pregnant women with Müllerian duct anomaly: a biologic model for uteroplacental insufficiency. Am J Obstet Gynecol 1998, 178:1048-1053.
73. Burchell R.C., Creed F., Rasoulpour M., et al. Vascular anatomy of the human uterus and pregnancy wastage. Br J Obstet Gynaecol 1978, 85:698-706.
74. Andrews M.C., Jones H.W. Impaired reproductive performance of the unicornuate uterus: intrauterine growth retardation, infertility, and recurrent abortion in five cases. Am J Obstet Gynecol 1982, 144:173-176.
75. Alborzi S., Asadi N., Zolghadri J., et al. Laparoscopic metroplasty in bicornuate and didelphic uteri. Fertil Steril 2009, 92:352-355.
76. Brucker S.Y., Rall K., Campo R., et al. Treatment of congenital malformations. Semin Reprod Med 2011, 29:101-112.
77. Rackow B.W., Arici A. Reproductive performance of women with Müllerian anomalies. Curr Opin Obstet Gynecol 2007, 19:229-237.
78. Musich J.R., Behrman S.J. Obstetric outcome before and after metroplasty in women with uterine anomalies. Obstet Gynecol 1978, 52:63-66.
79. Kowalik C.R., Goddijn M., Emanuel M.H., et al. Metroplasty versus expectant management for women with recurrent miscarriage and a septate uterus. Cochrane Database Syst Rev 2011, (6). CD008576.
80. Valle R.F., Ekpo G.E. Hysteroscopic metroplasty for the septate uterus: review and meta-analysis. JMinim Invasive Gynecol 2013, 20:22-42.
81. Grimbizis G.F., Camus M., Tarlatzis B.C., et al. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update 2001, 7:161-174.
82. Daly D.C., Maier D., Soto-Albors C. Hysteroscopic metroplasty: six years' experience. Obstet Gynecol 1989, 73:201-205.
83. Lin P.C. Reproductive outcomes in women with uterine anomalies. JWomens Health (Larchmt) 2004, 13:33-39.
84. Ban-Frangez H., Tomazevic T., Virant-Klun I., et al. The outcome of singleton pregnancies after IVF/ICSI in women before and after hysteroscopic resection of a uterine septum compared to normal controls. Eur J Obstet Gynecol Reprod Biol 2009, 146:184-187.
85. Gergolet M., Campo R., Verdenik I., et al. No clinical relevance of the height of fundal indentation in subseptate or arcuate uterus: a prospective study. Reprod Biomed Online 2012, 24:576-582.
86. Giacomucci E., Bellavia E., Sandri F., et al. Term delivery rate after hysteroscopic metroplasty in patients with recurrent spontaneous abortion and T-shaped, arcuate and septate uterus. Gynecol Obstet Invest 2011, 71:183-188.
87. Golan A., Langer R., Wexler S., et al. Cervical cerclage-its role in the pregnant anomalous uterus. Int J Fertil 1990, 35:164-170.
88. Ventolini G., Zhang M., Gruber J. Hysteroscopy in the evaluation of patients with recurrent pregnancy loss: a cohort study in a primary care population. Surg Endosc 2004, 18:1782-1784.
89. Dendrinos S., Grigoriou O., Sakkas E.G., et al. Hysteroscopy in the evaluation of habitual abortions. Eur J Contracept Reprod Health Care 2008, 13:198-200.
90. Guimarães Filho H.A., Mattar R., Pires C.R., et al. Prevalence of uterine defects in habitual abortion patients attended on at a university health service in Brazil. Arch Gynecol Obstet 2006, 274:345-348.
91. Cogendez E., Dolgun Z.N., Sanverdi I., et al. Post-abortion hysteroscopy: a method for early diagnosis of congenital and acquired intrauterine causes of abortions. Eur J Obstet Gynecol Reprod Biol 2011, 156:101-104.
92. Raziel A., Arieli S., Bukovsky I., et al. Investigation of the uterine cavity in recurrent aborters. Fertil Steril 1994, 62:1080-1082.
93. Coulam C.B. Epidemiology of recurrent spontaneous abortion. Am J Reprod Immunol 1991, 26:23-27.
94. March C.M. Management of Asherman's syndrome. Reprod Biomed Online 2011, 23:63-76.
95. Yu D., Wong Y.M., Cheong Y., et al. Asherman syndrome-one century later. Fertil Steril 2008, 89:759-779.
96. Foix A., Bruno R.O., Davison T., et al. The pathology of postcurettage intrauterine adhesions. Am J Obstet Gynecol 1966, 96:1027-1033.
97. Valle R.F., Sciarra J.J. Intrauterine adhesions: hysteroscopic diagnosis, classification, treatment, and reproductive outcome. Am J Obstet Gynecol 1988, 158:1459-1470.
98. Al-Inany H. Intrauterine adhesions. An update. Acta Obstet Gynecol Scand 2001, 80:986-993.
99. Schenker J.G., Margalioth E.J. Intrauterine adhesions: an updated appraisal. Fertil Steril 1982, 37:593-610.
100. Deans R., Abbott J. Review of intrauterine adhesions. JMinim Invasive Gynecol 2010, 17:555-569.
101. Friedler S., Margalioth E.J., Kafka I., et al. Incidence of post-abortion intra-uterine adhesions evaluated by hysteroscopy-a prospective study. Hum Reprod 1993, 8:442-444.
102. Westendorp I.C., Ankum W.M., Mol B.W., et al. Prevalence of Asherman's syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion. Hum Reprod 1998, 13:3347-3350.
103. Romer T. Post-abortion-hysteroscopy-a method for early diagnosis of congenital and acquired intrauterine causes of abortions. Eur J Obstet Gynecol Reprod Biol 1994, 57:171-173.
104. Li T.C., Iqbal T., Anstie B., et al. An analysis of the pattern of pregnancy loss in women with recurrent miscarriage. Fertil Steril 2002, 78:1100-1106.
105. Cooper J.M., Houck R.M., Rigberg H.S. The incidence of intrauterine abnormalities found at hysteroscopy in patients undergoing elective hysteroscopic sterilization. JReprod Med 1983, 28:659-661.
106. Fatemi H.M., Kasius J.C., Timmermans A., et al. Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to invitro fertilization. Hum Reprod 2010, 25:1959-1965.
107. Taylor P.J., Cumming D.C., Hill P.J. Significance of intrauterine adhesions detected hysteroscopically in eumenorrheic infertile women and role of antecedent curettage in their formation. Am J Obstet Gynecol 1981, 139:239-242.
108. Polishuk W.Z., Sadovsky E. Asyndrome of recurrent intrauterine adhesions. Am J Obstet Gynecol 1975, 123:151-158.
109. Yaffe H., Ron M., Polishuk W.Z. Amenorrhea, hypomenorrhea, and uterine fibrosis. Am J Obstet Gynecol 1978, 130:599-601.
110. Polishuk W.Z., Siew F.P., Gordon R., et al. Vascular changes in traumatic amenorrhea and hypomenorrhea. Int J Fertil 1977, 22:189-192.
111. Yu D., Li T.C., Xia E., et al. Factors affecting reproductive outcome of hysteroscopic adhesiolysis for Asherman's syndrome. Fertil Steril 2008, 89:715-722.
112. Ciarmela P., Islam M.S., Reis F.M., et al. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Hum Reprod Update 2011, 17:772-790.
113. Flake G.P., Andersen J., Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003, 111:1037-1054.
114. Richards P.A., Richards P.D., Tiltman A.J. The ultrastructure of fibromyomatous myometrium and its relationship to infertility. Hum Reprod Update 1998, 4:520-525.
115. Malik M., Norian J., McCarthy-Keith D., et al. Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women. Semin Reprod Med 2010, 28:169-179.
116. Moore A.B., Yu L., Swartz C.D., et al. Human uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF beta receptor signaling in coculture. Cell Commun Signal 2010, 8:10.
117. Islam M.S., Protic O., Stortoni P., et al. Complex networks of multiple factors in the pathogenesis of uterine leiomyoma. Fertil Steril 2013, 100(1):178-193.
118. Eiletz J., Genz T., Pollow K., et al. Sex steroid levels in serum, myometrium, and fibromyomata in correlation with cytoplasmic receptors and 17 beta-HSD activity in different age-groups and phases of the menstrual cycle. Arch Gynecol 1980, 229:13-28.
119. Bakas P., Liapis A., Vlahopoulos S., et al. Estrogen receptor alpha and beta in uterine fibroids: a basis for altered estrogen responsiveness. Fertil Steril 2008, 90:1878-1885.
120. Lv J., Zhu X., Dong K., et al. Reduced expression of 14-3-3 gamma in uterine leiomyoma as identified by proteomics. Fertil Steril 2008, 90:1892-1898.
121. Suo G., Jiang Y., Cowan B., et al. Platelet-derived growth factor C is upregulated in human uterine fibroids and regulates uterine smooth muscle cell growth. Biol Reprod 2009, 81:749-758.
122. Murase E., Siegelman E.S., Outwater E.K., et al. Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment. Radiographics 1999, 19:1179-1197.
123. Bajekal N., Li T.C. Fibroids, infertility and pregnancy wastage. Hum Reprod Update 2000, 6:614-620.
124. Ligon A.H., Morton C.C. Genetics of uterine leiomyomata. Genes Chromosomes Cancer 2000, 28:235-245.
125. Brosens I., Deprest J., Dal Cin P., et al. Clinical significance of cytogenetic abnormalities in uterine myomas. Fertil Steril 1998, 69:232-235.
126. Rein M.S., Powell W.L., Walters F.C., et al. Cytogenetic abnormalities in uterine myomas are associated with myoma size. Mol Hum Reprod 1998, 4:83-86.
127. Asada H., Yamagata Y., Taketani T., et al. Potential link between estrogen receptor-alpha gene hypomethylation and uterine fibroid formation. Mol Hum Reprod 2008, 14:539-545.
128. Linder D., Gartler S.M. Glucose-6-phosphate dehydrogenase mosaicism: utilization as a cell marker in the study of leiomyomas. Science 1965, 150:67-69.
129. Vikhlyaeva E.M., Khodzhaeva Z.S., Fantschenko N.D. Familial predisposition to uterine leiomyomas. Int J Gynaecol Obstet 1995, 51:127-131.
130. Baird D.D., Dunson D.B., Hill M.C., et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003, 188:100-107.
131. Marshall L.M., Spiegelman D., Barbieri R.L., et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997, 90:967-973.
132. Eggert S.L., Huyck K.L., Somasundaram P., et al. Genome-wide linkage and association analyses implicate FASN in predisposition to uterine leiomyomata. Am J Hum Genet 2012, 91:621-628.
133. Hodge J.C., T Cuenco K., Huyck K.L., et al. Uterine leiomyomata and decreased height: a common HMGA2 predisposition allele. Hum Genet 2009, 125:257-263.
134. Cramer S.F., Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990, 94:435-438.
135. Borgfeldt C., Andolf E. Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25-40 years. Acta Obstet Gynecol Scand 2000, 79:202-207.
136. Laughlin S.K., Baird D.D., Savitz D.A., et al. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study. Obstet Gynecol 2009, 113:630-635.
137. Marsh E.E., Ekpo G.E., Cardozo E.R., et al. Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18-30 years old): a pilot study. Fertil Steril 2013, 99:1951-1957.
138. Klatsky P.C., Tran N.D., Caughey A.B., et al. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol 2008, 198:357-366.
139. Pritts E.A., Parker W.H., Olive D.L. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009, 91:1215-1223.
140. Sunkara S.K., Khairy M., El-Toukhy T., et al. The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis. Hum Reprod 2010, 25:418-429.
141. Saravelos S.H., Yan J., Rehmani H., et al. The prevalence and impact of fibroids and their treatment on the outcome of pregnancy in women with recurrent miscarriage. Hum Reprod 2011, 26:3274-3279.
142. Deligdish L., Loewenthal M. Endometrial changes associated with myomata of the uterus. JClin Pathol 1970, 23:676-680.
143. Sinclair D.C., Mastroyannis A., Taylor H.S. Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-beta3. JClin Endocrinol Metab 2011, 96:412-421.
144. Makker A., Goel M.M. Uterine leiomyomas: effects on architectural, cellular, and molecular determinants of endometrial receptivity. Reprod Sci 2013, 20:631-638.
145. Miura S., Khan K.N., Kitajima M., et al. Differential infiltration of macrophages and prostaglandin production by different uterine leiomyomas. Hum Reprod 2006, 21:2545-2554.
146. Guo X.C., Segars J.H. The impact and management of fibroids for fertility: an evidence-based approach. Obstet Gynecol Clin North Am 2012, 39:521-533.
147. Roy K.K., Singla S., Baruah J., et al. Reproductive outcome following hysteroscopic myomectomy in patients with infertility and recurrent abortions. Arch Gynecol Obstet 2010, 282:553-560.
148. Shokeir T.A. Hysteroscopic management in submucous fibroids to improve fertility. Arch Gynecol Obstet 2005, 273:50-54.
149. Metwally M., Cheong Y.C., Horne A.W. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev 2012, (11). CD003857.
150. Casini M.L., Rossi F., Agostini R., et al. Effects of the position of fibroids on fertility. Gynecol Endocrinol 2006, 22:106-109.
151. Di Spiezio Sardo A., Mazzon I., Bramante S., et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update 2008, 14:101-119.
152. Homer H., Saridogan E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril 2010, 94:324-330.
153. Peterson W.F., Novak E.R. Endometrial polyps. Obstet Gynecol 1956, 8:40-49.
154. Dreisler E., Stampe Sorensen S., Ibsen P.H., et al. Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years. Ultrasound Obstet Gynecol 2009, 33:102-108.
155. Onalan R., Onalan G., Tonguc E., et al. Body mass index is an independent risk factor for the development of endometrial polyps in patients undergoing invitro fertilization. Fertil Steril 2009, 91:1056-1060.
156. Dal Cin P., Vanni R., Marras S., et al. Four cytogenetic subgroups can be identified in endometrial polyps. Cancer Res 1995, 55:1565-1568.
157. Indraccolo U., Di Iorio R., Matteo M., et al. The pathogenesis of endometrial polyps: a systematic semi-quantitative review. Eur J Gynaecol Oncol 2013, 34:5-22.
158. Maia H., Pimentel K., Silva T.M., et al. Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle. Gynecol Endocrinol 2006, 22:219-224.
159. Clevenger-Hoeft M., Syrop C.H., Stovall D.W., et al. Sonohysterography in premenopausal women with and without abnormal bleeding. Obstet Gynecol 1999, 94:516-520.
160. Perez-Medina T., Bajo-Arenas J., Salazar F., et al. Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomized study. Hum Reprod 2005, 20:1632-1635.
161. Devi Wold A.S., Pham N., Arici A. Anatomic factors in recurrent pregnancy loss. Semin Reprod Med 2006, 24:25-32.
162. Bosteels J., Kasius J., Weyers S., et al. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst Rev 2013, (1). CD009461.
163. Check J.H., Bostick-Smith C.A., Choe J.K., et al. Matched controlled study to evaluate the effect of endometrial polyps on pregnancy and implantation rates following invitro fertilization-embryo transfer (IVF-ET). Clin Exp Obstet Gynecol 2011, 38:206-208.
164. Lass A., Williams G., Abusheikha N., et al. The effect of endometrial polyps on outcomes of invitro fertilization (IVF) cycles. JAssist Reprod Genet 1999, 16:410-415.
165. Lieng M., Istre O., Sandvik L., et al. Prevalence, 1-year regression rate, and clinical significance of asymptomatic endometrial polyps: cross-sectional study. JMinim Invasive Gynecol 2009, 16:465-471.